ATE554790T1 - Verfahren und zusammensetzungen zur diagnose von asthma - Google Patents
Verfahren und zusammensetzungen zur diagnose von asthmaInfo
- Publication number
- ATE554790T1 ATE554790T1 AT02795780T AT02795780T ATE554790T1 AT E554790 T1 ATE554790 T1 AT E554790T1 AT 02795780 T AT02795780 T AT 02795780T AT 02795780 T AT02795780 T AT 02795780T AT E554790 T1 ATE554790 T1 AT E554790T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- diagnosing asthma
- asthma
- diagnosing
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/53—Colony-stimulating factor [CSF]
- G01N2333/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5406—IL-4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5425—IL-9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5446—IL-16
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33838901P | 2001-12-07 | 2001-12-07 | |
| PCT/US2002/039198 WO2003049599A2 (en) | 2001-12-07 | 2002-12-09 | Methods and compositions for the diagnosis of asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554790T1 true ATE554790T1 (de) | 2012-05-15 |
Family
ID=23324626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02795780T ATE554790T1 (de) | 2001-12-07 | 2002-12-09 | Verfahren und zusammensetzungen zur diagnose von asthma |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050036943A1 (de) |
| EP (1) | EP1450859B1 (de) |
| JP (1) | JP4489431B2 (de) |
| AT (1) | ATE554790T1 (de) |
| AU (1) | AU2002360519B2 (de) |
| CA (1) | CA2469459C (de) |
| WO (1) | WO2003049599A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140023656A1 (en) * | 2010-09-24 | 2014-01-23 | BioLT CO., LTD. | Pharmaceutical composition for treatment and prevention of th3 march-related diseases |
| JP2015530560A (ja) * | 2012-06-15 | 2015-10-15 | エルビズ，エクレム | Ｅｌｉｓａ法におけるゲルを含むｅｄｔａチューブ及び該チューブを使用する分析器 |
| JP7033774B2 (ja) * | 2017-08-25 | 2022-03-11 | 国立大学法人 東京大学 | 抗サイトカイン抗体療法 |
| US11925485B2 (en) | 2017-12-06 | 2024-03-12 | Cardiac Pacemakers, Inc. | Non-invasive system for monitoring and treating respiratory distress |
| US11690559B2 (en) * | 2017-12-06 | 2023-07-04 | Cardiac Pacemakers, Inc. | Method and apparatus for monitoring respiratory distress based on autonomic imbalance |
| WO2021245025A1 (en) * | 2020-06-01 | 2021-12-09 | Loop Diagnostics, S.L. | Method and kit for the early detection of sepsis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4366241A (en) * | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US5843440A (en) * | 1990-10-03 | 1998-12-01 | Redcell Canada, Inc. | Cellular and serum protein anchors for modulating pharmacokinetics |
| US6156503A (en) * | 1997-03-03 | 2000-12-05 | The Regents Of The University Of California | Diagnosing asthma patients predisposed to adverse β-agonist reactions |
| US6306897B1 (en) * | 1999-03-19 | 2001-10-23 | Parker Hughes Institute | Calanolides for inhibiting BTK |
| US6846486B1 (en) * | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
| US6630176B2 (en) * | 2000-03-07 | 2003-10-07 | Mount Sinai School Of Medicine Of New York University | Herbal remedies for treating allergies and asthma |
| US7384736B2 (en) * | 2001-09-06 | 2008-06-10 | Decode Genetics Ehf. | Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
-
2002
- 2002-12-09 AT AT02795780T patent/ATE554790T1/de active
- 2002-12-09 US US10/497,618 patent/US20050036943A1/en not_active Abandoned
- 2002-12-09 EP EP02795780A patent/EP1450859B1/de not_active Expired - Lifetime
- 2002-12-09 JP JP2003550652A patent/JP4489431B2/ja not_active Expired - Fee Related
- 2002-12-09 CA CA2469459A patent/CA2469459C/en not_active Expired - Fee Related
- 2002-12-09 WO PCT/US2002/039198 patent/WO2003049599A2/en not_active Ceased
- 2002-12-09 AU AU2002360519A patent/AU2002360519B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20050036943A1 (en) | 2005-02-17 |
| AU2002360519B2 (en) | 2008-09-25 |
| AU2002360519A1 (en) | 2003-06-23 |
| EP1450859B1 (de) | 2012-04-25 |
| CA2469459C (en) | 2011-10-18 |
| WO2003049599A3 (en) | 2003-12-18 |
| EP1450859A4 (de) | 2005-11-02 |
| WO2003049599A2 (en) | 2003-06-19 |
| JP2005512068A (ja) | 2005-04-28 |
| CA2469459A1 (en) | 2003-06-19 |
| JP4489431B2 (ja) | 2010-06-23 |
| EP1450859A2 (de) | 2004-09-01 |
| WO2003049599A8 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440536T1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| DE60329165D1 (de) | Detektion und/oder beobachtung von synuclein-assoziierten krankheiten | |
| EP1390077A4 (de) | Behandlung und diagnose vom makrophagen-vermittelter erkrankung | |
| DE60205433D1 (de) | Vorrichtung und Verfahren zur Auswertung der medizinischen Einrichtungen | |
| EP1553827A4 (de) | Medizinische vorrichtung und verfahren für die entfernung und reparatur von gewebe | |
| EP1539251A4 (de) | Zusammensetzungen und verfahren zur diagnose und therapie von medizinischen erkrankungen mit angiogenese | |
| ATE451477T1 (de) | Diagnose und überwachung von hepatozellulärem karzinom | |
| EP1550462A4 (de) | MITTEL ZUR BEHANDLUNG ODER PRûVENTION VON NIERENERKRANKUNGEN UND VERFAHREN ZUR DIAGNOSE VON NIERENERKRANKUNGEN | |
| EP1446013A4 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| ATE554790T1 (de) | Verfahren und zusammensetzungen zur diagnose von asthma | |
| EP1573440A4 (de) | Verfahren zur diagnose von akathisie | |
| DE60122673D1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
| DK0764273T3 (da) | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose | |
| EP1496743A4 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| DE60038614D1 (de) | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen | |
| DE50007635D1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| ATE320272T1 (de) | Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung | |
| BR0007702A (pt) | Método e kit de diagnóstico para diagnose de endometriose | |
| DE60134158D1 (de) | Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs | |
| ATE472611T1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
| ATE390435T1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie | |
| RU2001120628A (ru) | Способ диагностики активности туберкулеза органов дыхания | |
| PT745221E (pt) | Reticulacoes de piridinolina como marcadores de actividade de doenca peridental e peri-implante | |
| EP1357834A4 (de) | Diagnose von atmungsstörungen im schlaf | |
| DE50214523D1 (de) | Nukleotidträger zur diagnose und therapie oraler erkrankungen |